1Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature,2001,414:105 - 111.
2Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[ J]. Nat Med, 1997,3 (7) :730 - 737.
3AI Hajj M, Wicha MS, Benit Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells. [ J ] Proc Nat Acad Sci USA,2003,100 (7) :3983 - 3988.
4Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors [ J ]. Cancer Res, 2003,63 (18 ) : 5821 - 5828.
5Oliver JA, Maarouf O, Cheema FH, et al. The renal papilla is a niche for adult kidney stem cells [ J ]. J Clin Invest,2004,114:795 -804.
6Iwatani H, ho T, Imai E, et al. Hematopoietic and nonhematopoietic potentials of Hoechst (low)/side population cells isolated from adult rat kidney[ J]. Kidney Int,2004,65 : 1604 - 1614.
7Challen GA, Little MH. A side order of stem cells:the SP phenotype[ J]. Stem Cells ,2006,24:3 - 12.
8Bussolati B, Bruno S, Grange C, et al. Isolation of renal progenitor cells from adult human kidney[ J]. Am J Pathol,2005,166:545 - 555.
9Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys [ J ]. J Am Soc Nephrol, 2006, 17 : 2443 - 2456.
10Kitamura S, Yamasaki Y, Kinomura M, et al. Establishment and characterization of renal progenitor - like cells from S3 segment of nephron in rat adult kidney [ J ]. FASEB J, 2005,19 : 1789 - 1797.
6Finley DS,Pantuck AJ,Belldegrun AS.Tumor biology and prognos-tic factors in renal cell carcinoma[J].Oncologist,2011,16(Suppl2):4-13.
7Senan S,Smit EF.Design of clinical trials of radiation combined withantiangiogenic therapy[J].Oncologist,2007,12(4),465-477.
8Escudier B,Bellmunt J,Négrier S,et al.PhaseⅢtrial of bevaci-zumab plus interferon alfa-2a in patients with metastatic renal cellcarcinoma(AVOREN):final analysis of overall survival[J].J ClinOncol,2010,28(13):2144-2150.
9Rini BI,Halabi S,Rosenberg JE,et al.Bevacizumab plus interferonalfa compared with interferon alfa monotherapy in patients withmetastatic renal cell carcinoma:CALGB 90206[J].J Clin Oncol,2008,26(33):5422-5428.
10Tamaskar IB,Rini B,Mekhail T,et al.A phaseⅡtrial of low doseinterleukin-2(IL-2)and bevaeizumab for patients(pts)with meta-static renal cell carcinoma(mRCC)[J].J Clin Oncol,2007,25(18S):5103.
